FLT3 inhibitors for the treatment of autoimmune disease.
D000818:Animals; D001327:Autoimmune Diseases / Q000188:drug therapy* / Q000201:enzymology* / Q000235:genetics / Q000276:immunology; D003713:Dendritic Cells / Q000276:immunology; D004353:Drug Evaluation, Preclinical; D006801:Humans; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D015398:Signal Transduction / Q000187:drug effects; D051941:fms-Like Tyrosine Kinase 3 / Q000037:antagonists & inhibitors* / Q000378:metabolism
D047428:Protein Kinase Inhibitors; D051941:fms-Like Tyrosine Kinase 3